Synapse - Works

Results (22057)

Pooled safety analysis from phase 3 studies of trifluridine/tipiracil (FTD/TPI) in patients (pts) with metastatic gastric/gastroesophageal junction cancer (mGC/mGEJC) and metastatic colorectal cancer (mCRC)

Meeting Abstract

Van Cutsem, E.; Hochster, H. S.; Shitara, K.; Mayer, R. J.; Ohtsu, A.; Falcone, A.; Yoshino, T.; Doi, T.; Ilson, D. H.; Arkenau, H. T.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Adjuvant enzalutamide for the treatment of early-stage androgen receptor-positive (AR plus ) TNBC

Meeting Abstract

Traina, T. A.; Boyle, L. A.; Arumov, A.; Patil, S.; Edelweiss, M.; DeFusco, P. A.; Gorsky, M.; Lamparella, N. E.; Modi, S.; Sanford, R. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

APACT: phase III, multicenter, international, open-label, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) for surgically resected pancreatic adenocarcinoma

Meeting Abstract

Tempero, M. A.; Reni, M.; Riess, H.; Pelzer, U.; O'Reilly, E. M.; Winter, J. M.; Oh, D. Y.; Li, C. P.; Tortora, G.; Chang, H. M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A retrospective analysis of cisplatin dosing strategies when used with radiation on outcomes in head and neck squamous cell carcinoma of the oropharynx

Meeting Abstract

Tchekmedyian, V.; Ho, A. L.; Dunn, L.; Fetten, J. V.; Pfister, D. G.; Lobaugh, S.; Zhang, Z.; Kang, J.; Chen, L.; Riaz, N.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A phase II trial cohort of nivolumab plus ipilimumab in patients (Pts) with recurrent/metastatic adenoid cystic carcinoma (R/M ACC)

Meeting Abstract

Tchekmedyian, V.; Sherman, E. J.; Dunn, L.; Fetten, J. V.; Michel, L. S.; Kriplani, A.; Morris, L.; Ostrovnaya, I.; Katabi, N.; Haque, S.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Efficacy and safety of the combination of nivolumab (NIVO) plus ipilimumab (IPI) in patients with symptomatic melanoma brain metastases (CheckMate 204)

Meeting Abstract

Tawbi, H. A. H.; Forsyth, P. A. J.; Hodi, F. S.; Lao, C. D.; Moschos, S. J.; Hamid, O.; Atkins, M. B.; Lewis, K. D.; Thomas, R. P.; Glaspy, J. A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Responder analysis of patient-reported outcomes measurement information system (PROMIS) physical function (PF) and worst stiffness among patients with tenosynovial giant cell tumors (TGCT) in the ENLIVEN study

Meeting Abstract

Tap, W. D.; Speck, R. M.; Ye, X.; Palmerini, E.; Stacchiotti, S.; Desai, J.; Wagner, A. J.; Alcindor, T.; Ganjoo, K. N.; Broto, J. M.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Ten-fold increase in genetic testing in pancreatic and metastatic prostate cancer with implementation of point of care (POC) testing

Meeting Abstract

Symecko, H.; Mueller, R.; Spielman, K.; Batson, M.; Pundock, S.; Hamilton, J. G.; Robson, M. E.; Domchek, S. M.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

PROTEUS: A randomized, double-blind, placebo (PBO)-controlled, phase 3 trial of apalutamide (APA) plus androgen deprivation therapy (ADT) versus PBO plus ADT prior to radical prostatectomy (RP) in patients with localized high-risk or locally advanced prostate cancer (PC)

Meeting Abstract

Taplin, M. E.; Gleave, M.; Evans, C. P.; Efstathiou, E.; Kantoff, P. W.; Ross, A.; Shore, N. D.; Briganti, A.; Hadaschik, B. A.; Heidenreich, A.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

A phase Ib/II study of niraparib combination therapies for the treatment of metastatic castration-resistant prostate cancer (NCT03431350)

Meeting Abstract

Subudhi, S. K.; Aparicio, A.; Zurita, A. J.; Doger, B.; Kelly, W. K.; Peer, A.; Rathkopf, D. E.; Karsh, L. I.; Tryon, J. J.; Kothari, N.; more...
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save